Automation and artificial intelligence (AI) will be key to a new effort to manufacture millions of RNA vaccines in Africa, according to Cairo, Egypt-headquartered drug firm Eva Pharma. Eva Pharma made ...
MIT chemical engineers have built an automated, self-correcting platform that rapidly produces lipid nanoparticles of ...
Programmable nucleic acid nanoparticles boost vaccine immune responses as effectively as standard adjuvants in mice while avoiding the autoimmune risks that limit existing alternatives. (Nanowerk ...
Hosted on MSN
New norovirus vaccine approach may shape strategies for treating other RNA viruses as well
Every RNA virus—from stomach bugs and influenza to measles and the common cold—has its own story to tell, with a unique combination of symptoms, transmission rates, duration and chemical blueprint.
As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.
The FDA approved an mRNA seasonal influenza vaccine offering enhanced protection for adults aged 50 years or older compared with standard vaccines. The Conversation — Vaccines have been reliably and ...
What is an RNA vaccine? RNA vaccines, or messenger RNA (mRNA) vaccines, are a relatively new type of vaccine that delivers mRNA molecules to human cells, instructing them to produce specific antigens.
Learn how messenger RNA, spike protein, and lipid nanoparticles drive rapid advances in vaccines and cancer therapies, reshaping modern medicine with precision and speed. Pixabay, spencerbdavis1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results